Private Equity
Gili Elkin from the Israel - Colorado Innovation Fund says after taking more than 700 meetings with start-ups, she found that fewer than 10 had female CEOs. Here’s what she's doing about it.
3 min read · 26 May 2021
There's an inflection point taking place in Japan that is creating opportunities for foreign investors, according to Koichiro Nakamura of Sozo Ventures.
3 min read · 05 May 2021
Anis Uzzaman of Pegasus Tech Ventures argues there is a new era of transportation for consumers to use micromobility solutions in addition to autonomous vehicles.
3 min read · 28 April 2021
The market continues to evolve, writes Mark Donnelly, managing director at Runway Growth Capital, who says he is seeing larger debt facilities, lower cost of capital, lighter covenants and less amortization.
3 min read · 06 April 2021
Sozo Ventures managing directors Phil Wickham and Koichiro Nakamura discuss that the stage is set in Japan for VCs and their LPs for an explosion of investment opportunities. Can Tokyo’s old guard get out of the way fast enough?
4 min read · 03 February 2021
Issac Roth of Shasta Ventures looks ahead to the new year. He says the new presidential administration won't much impact tech. He also sees trends with firm specialization and synthetic biology.
4 min read · 12 January 2021
Bernard Ross of Sky Medical Technology says that the European medtech market has grown in recent years and he expects it to keep rising since the region is ripe with innovation.
3 min read · 29 October 2020
Matt McCooe of Connecticut Innovations writes that the stereotypical successful tech entrepreneur is not a nerdy white guy in jeans from Silicon Valley. Investors need to broaden their lens.
3 min read · 20 October 2020
Covid-19 has created uncertainty, and it has also paved the way for opportunities in certain sectors. Anis Uzzaman of Pegasus Tech Ventures says e-commerce, online education and e-sports are the three sectors that will remain relevant long after the pandemic.
4 min read · 07 October 2020
Tom Walker of Rev1 Ventures addresses the question of whether investors should back biotech start-ups that focus on the coronavirus and other potential pandemics. Here's what you should know.
4 min read · 25 August 2020